Senior Director Transactions, Johnson & Johnson Innovation Center
Carolyne Zimmermann is a Senior Director of Transactions at the Johnson & Johnson Innovation Center in Menlo Park, California. The mission of the Innovation Centers is to access the best science and technology to solve the greatest unmet medical needs of our time. We catalyze, support, and invest in highly differentiated early-stage innovations that have the potential to extend and improve lives.
Carolyne is a recent addition to the Johnson & Johnson Innovation Center and brings an extensive background of successful deal making to the Johnson and Johnson community with over 13 years of diverse experience in life sciences as a business development executive and venture investor with Novartis Pharmaceuticals. In her most recent role, Carolyne was as a General Partner to dRx Capital a $100mn venture fund founded in 2015 by Novartis and Qualcomm focused on early stage digital health investing. Prior to this, she led the Business Development and Licensing efforts for the Global Cardio-Metabolic Franchise where she was responsible for driving the external strategy and securing strategic assets to expand the portfolio. During her tenure at Novartis, Carolyne also led transactions and alliances in the areas of Respiratory, Immunology, Tropical Diseases and Digital Medicine.
Carolyne earned her BS degree in Engineering Sciences from the University of California, San Diego and her MBA from Columbia Business School in New York.